The 2026 timeframe, Altucher argues in the video, reflects this convergence. It coincides with Starlink’s expanding satellite constellation, rising traffic volumes, and increasing role in global ...
ORKA-001, a novel half-life extended IL-23p19 monoclonal antibody (mAb), first-in-human dosing now expected first quarter 2025 ORKA-002, a novel half-life extended IL-17A/F mAb, first-in-human dosing ...
SPY003, a novel half-life extended IL-23p19 monoclonal antibody (mAb), with first-in-human dosing now expected first quarter 2025 New data on SPY003 presented at UEGW demonstrating robust preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback